Publications

1. Nakkireddy SR, Jang I, Kim M, Yin LX, Rivera M, Garcia JJ, Bartemes KR, Routman DM, Moore EJ, Abdel-Halim CN, Ma DJ, Van Abel KM, Hwang TH. Integrative analysis of H&E and IHC identifies prognostic immune subtypes in HPV related oropharyngeal cancer. Commun Med (Lond). 2024 Oct 3; 4 (1):190 Epub 2024 Oct 03
   View PubMed
2. Butterfield JH, Bartemes K. Metformin: A potential adjunct for treatment of systemic mastocytosis. J Allergy Clin Immunol Glob. 2024 Feb; 3 (1):100186 Epub 2023 Nov 07
   View PubMed
3. Bartemes KR, Gochanour BR, Routman DM, Ma DJ, Doering KA, Burger KN, Foote PH, Taylor WR, Mahoney DW, Berger CK, Cao X, Then SS, Haller TJ, Larish AM, Moore EJ, Garcia JJ, Graham RP, Bakkum-Gamez JN, Kisiel JB, Van Abel KM. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease. Oral Oncol. 2023 Nov; 146:106568 Epub 2023 Sept 16
   View PubMed
4. Yin LX, Rivera M, Garcia JJ, Bartemes KR, Lewis DB, Lohse CM, Routman DM, Ma DJ, Moore EJ, Van Abel KM. Impact of Tumor-Infiltrating Lymphocytes on Disease Progression in Human Papillomavirus-Related Oropharyngeal Carcinoma. Otolaryngol Head Neck Surg. 2023 Sep; 169 (3):539-547 Epub 2023 Jan 30
   View PubMed
5. Yin LX, Routman DM, Day CN, Harmsen WS, Haller T, Bartemes K, Price DL, Moore EJ, Foote RL, Neben-Wittich M, Chintakuntlawar AV, Ma DJ, Price KA, Van Abel KM. Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer. Head Neck. 2022 Dec; 44(12):2760-2768. Epub 2022 Sep 21.
   View PubMed
6. Bowen AJ, Ekbom DC, Hunter D, Voss S, Bartemes K, Mearns-Spragg A, Oldenburg MS, San-Marina S. Larynx proteomics after jellyfish collagen IL: Increased ECM/collagen and suppressed inflammation. Laryngoscope Investig Otolaryngol. 2022 Oct; 7 (5):1513-1520 Epub 2022 Sept 24
   View PubMed
7. Bowen AJ, San-Marina S, Hunter D, Voss S, Bartemes K, Macura S, Meloche R, Spragg AM, Lohse C, Oldenburg MS, Ekbom DC. MRI imaging versus histologic volumetric estimation of residual injection laryngoplasty material. Laryngoscope Investig Otolaryngol. 2022 Apr; 7 (2):454-459 Epub 2022 Feb 02
   View PubMed
8. Choby G, Low CM, Levy JM, Stokken JK, Pinheiro-Neto C, Bartemes K, Marino M, Han JK, Divekar R, O'Brien EK, Lal D. Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2022 Feb; 166(2):224-232. Epub 2021 May 11.
   View PubMed
9. Bartemes KR, Choby G, O'Brien EK, Stokken JK, Pavelko KD, Kita H. Mass cytometry reveals unique subsets of T cells and lymphoid cells in nasal polyps from patients with chronic rhinosinusitis (CRS). Allergy 2021 Jul; 76 (7):2222-2226 Epub 2021 Jan 19
   View PubMed
10. Bartemes KR, Kita H. Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s. J Allergy Clin Immunol. 2021 May; 147 (5):1531-1547
    View PubMed
11. Drake LY, Bartemes KR, Bachman KA, Hagan JB, Kita H. In vitro Culture with Cytokines Provides a Tool to Assess the Effector Functions of ILC2s in Peripheral Blood in Asthma. J Asthma Allergy. 2021; 14:13-22 Epub 2021 Jan 11
    View PubMed
12. Van Abel KM, Routman DM, Moore EJ, Ma DJ, Yin LX, Fields PA, Schofield M, Bartemes KR, Chatzopoulos K, Price DL, Janus JR, Kasperbauer JL, Price KA, Chintakuntlawar AV, Neben-Wittich MA, Foote RL, Garcia JJ. T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma. Oral Oncol. 2020 Dec; 111:104894 Epub 2020 July 23
    View PubMed
13. Bartemes KR, Kita H. Innate and adaptive immune responses to fungi in the airway. J Allergy Clin Immunol. 2018 Aug; 142 (2):353-363
    View PubMed
14. Bartemes K, Chen CC, Iijima K, Drake L, Kita H. IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus. J Immunol. 2018 Jan 1; 200 (1):229-236 Epub 2017 Nov 13
    View PubMed
15. Drake LY, Iijima K, Bartemes K, Kita H. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice. J Immunol. 2016 Aug 15; 197 (4):1335-42 Epub 2016 July 15
    View PubMed
16. Anderson EL, Kobayashi T, Iijima K, Bartemes KR, Chen CC, Kita H. IL-33 mediates reactive eosinophilopoiesis in response to airborne allergen exposure. Allergy. 2016 Jul; 71 (7):977-88 Epub 2016 Mar 02
    View PubMed
17. Bartemes KR, Kephart GM, Fox SJ, Kita H. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014 Sep; 134 (3):671-678.e4
    View PubMed
18. Bartemes KR, Kita H. Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol. 2012 Jun; 143 (3):222-35 Epub 2012 Mar 20
    View PubMed
19. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol. 2012 Feb 1; 188 (3):1503-13 Epub 2011 Dec 23
    View PubMed
20. Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol. 2009 May; 123 (5):1047-54 Epub 2009 Apr 10
    View PubMed
21. Bankers-Fulbright JL, Bartemes KR, Kephart GM, Kita H, O'Grady SM. Beta-2-integrin-mediated adhesion and intracellular Ca2+ release in human eosinophils. J Memb Biol. 2009; 228:99-109.
    
22. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008 Jun; 121 (6):1484-90
    View PubMed
23. Volcheck GW, Kelkar P, Bartemes KR, Gleich GJ, Kita H. Effects of (R)- and (S)-isomers of beta-adrenergic agonists on eosinophil response to interleukin-5. Clin Exp Allergy. 2005 Oct; 35(10):1341-6.
    View PubMed
24. Bartemes KR, Cooper KM, Drain KL, Kita H. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol. 2005 Oct; 116(4):827-35.
    View PubMed
25. Bankers-Fulbright JL, Kephart GM, Bartemes KR, Kita H, O'Grady SM. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. J Cell Sci. 2004 Nov 15; 117 (Pt 24):5749-57 Epub 2004 Oct 26
    View PubMed
26. Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. Journal of Allergy & Clinical Immunology. 2004 Sep; 114(3):568-74.
    View PubMed
27. Kita H, Jorgensen RK, Reed CE, Dunnette SL, Swanson MC, Bartemes KR, Squillace D, Blomgren J, Bachman K, Gleich GJ. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected. J Allergy Clin Immunol. 2000 Sep; 106(3):521-9.
    View PubMed
28. Kita H, Kaneko M, Bartemes KR, Weiler DA, Schimming AW, Reed CE, Gleich GJ. Does IgE bind to and activate eosinophils from patients with allergy? J Immunol. 1999 Jun 1; 162(11):6901-11.
    View PubMed
29. Bartemes KR, McKinney S, Gleich GJ, Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J Immunol. 1999 Mar 01; 162: (5)2982-9.
    View PubMed
30. Hagan JB, Bartemes KR, Kita H, Ottesen EA, Awadzi K, Nutman TB, Gleich GJ. Elevations in granulocyte-macrophage colony-stimulating factor and interleukin-5 levels precede posttreatment eosinophilia in onchocerciasis. J Infect Dis. 1996 May; 173 (5):1277-80
    View PubMed
31. Sur S, Gleich GJ, Swanson MC, Bartemes KR, Broide DH. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy Clin Immunol. 1995 Nov; 96 (5 Pt 1):661-8
    View PubMed
32. Sosman JA, Bartemes K, Offord KP, Kita H, Fisher SG, Kefer C, Ellis TA, Fisher RI, Higgins TJ, Gleich GJ. Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration. Clin Cancer Res. 1995 Aug; 1(8):805-12.
    View PubMed
33. Wagner JM, Bartemes K, Vernof KK, Dunnette S, Offord KP, Checkel JL, Gleich GJ. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta. 1993 Nov-Dec; 14 (6):671-81
    View PubMed
34. Collins DS, Dupuis R, Gleich GJ, Bartemes KR, Koh YY, Pollice M, Albertine KH, Fish JE, Peters SP. Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation. Am Rev Respir Dis. 1993 Mar; 147(3):677-83.
    View PubMed
35. Wasmoen TL, Wagner JM, Bartemes KR, Gleich GJ. Plasma levels of eosinophil granule major basic protein in pregnant cynomolgus monkeys. Placenta. 1992 May-Jun; 13 (3):265-72
    View PubMed
36. Tobian L, Johnson MA, Hanlon S, Bartemes K. A glomerular defect in prehypertensive Dahl S rats, which limits their capacity to increase GFR. Am J Hypertens. 1989 Jul; 2 (7):557-9
    View PubMed
37. Tobian L, Johnson MA, Hanlon S, Bartemes K. Prehypertensive Dahl S rats show no rise in glomerular filtration rate after an amino acid infusion. Trans Assoc Am Physicians. 1988; 101:292-6
    View PubMed